Michael Scott Salka - Net Worth and Insider Trading
Michael Scott Salka Net Worth
The estimated net worth of Michael Scott Salka is at least $70 dollars as of 2024-11-10. Michael Scott Salka is the CEO of Armata Pharmaceuticals Inc and owns about 30 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $70. Details can be seen in Michael Scott Salka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Scott Salka has not made any transactions after 2015-10-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Scott Salka
Michael Scott Salka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Scott Salka owns 2 companies in total, including Armata Pharmaceuticals Inc (ARMP) , and Sorrento Therapeutics Inc (SRNE) .
Click here to see the complete history of Michael Scott Salka’s form 4 insider trades.
Insider Ownership Summary of Michael Scott Salka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARMP | Armata Pharmaceuticals Inc | 2015-10-05 | director & Chief Executive Officer |
| SRNE | Sorrento Therapeutics Inc | 2012-02-23 | director |
Michael Scott Salka Latest Holdings Summary
Michael Scott Salka currently owns a total of 1 stock. Michael Scott Salka owns 30 shares of Armata Pharmaceuticals Inc (ARMP) as of October 5, 2015, with a value of $70.
Latest Holdings of Michael Scott Salka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals Inc | 2015-10-05 | 30 | 2.33 | 70 |
Holding Weightings of Michael Scott Salka
Michael Scott Salka Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Scott Salka has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 30 shares on October 5, 2015, which cost Michael Scott Salka around $19,950.
Insider Trading History of Michael Scott Salka
- 1
Michael Scott Salka Trading Performance
GuruFocus tracks the stock performance after each of Michael Scott Salka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Scott Salka is -9.5%. GuruFocus also compares Michael Scott Salka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Scott Salka within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Scott Salka's insider trading performs compared to the benchmark.
Performance of Michael Scott Salka
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 27.8 | | | | | |
| Relative Return to S&P 500(%) | 22.12 | | | | | |
Michael Scott Salka Ownership Network
Ownership Network List of Michael Scott Salka
Ownership Network Relation of Michael Scott Salka
Michael Scott Salka Owned Company Details
What does Armata Pharmaceuticals Inc do?
Who are the key executives at Armata Pharmaceuticals Inc?
Michael Scott Salka is the director & Chief Executive Officer of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .
Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Armata Pharmaceuticals Inc Insider Transactions
Michael Scott Salka Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Scott Salka. You might contact Michael Scott Salka via mailing address: Po Box 3577, Rancho Santa Fe Ca 92067-3577.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
